268 research outputs found
Analog power spectral density analysis of electroretinogram data
Analog power spectral density analysis of electroretinogram dat
Postoperative Adverse Outcomes in Intellectually Disabled Surgical Patients: A Nationwide Population-Based Study
Intellectually disabled patients have various comorbidities, but their risks of adverse surgical outcomes have not been examined. This study assesses pre-existing comorbidities, adjusted risks of postoperative major morbidities and mortality in intellectually disabled surgical patients.A nationwide population-based study was conducted in patients who underwent inpatient major surgery in Taiwan between 2004 and 2007. Four controls for each patient were randomly selected from the National Health Insurance Research Database. Preoperative major comorbidities, postoperative major complications and 30-day in-hospital mortality were compared between patients with and without intellectual disability. Use of medical services also was analyzed. Adjusted odds ratios using multivariate logistic regression analyses with 95% confidence intervals were applied to verify intellectual disability's impact.Controls were compared with 3983 surgical patients with intellectual disability. Risks for postoperative major complications were increased in patients with intellectual disability, including acute renal failure (odds ratio 3.81, 95% confidence interval 2.28 to 6.37), pneumonia (odds ratio 2.01, 1.61 to 2.49), postoperative bleeding (odds ratio 1.35, 1.09 to 1.68) and septicemia (odds ratio 2.43, 1.85 to 3.21) without significant differences in overall mortality. Disability severity was positively correlated with postoperative septicemia risk. Medical service use was also significantly higher in surgical patients with intellectual disability.Intellectual disability significantly increases the risk of overall major complications after major surgery. Our findings show a need for integrated and revised protocols for postoperative management to improve care for intellectually disabled surgical patients
Genetics and other factors in the aetiology of female pattern hair loss.
Pattern hair loss is the most common form of hair loss in both women and men. Male pattern hair loss, also termed male androgenetic alopecia (M-AGA), is an androgen-dependent trait that is predominantly genetically determined. Androgen-mediated mechanisms are probably involved in FPHL in some women but the evidence is less strong than in M-AGA; and other non-androgenic pathways, including environmental influences, may contribute to the aetiology. Genome-wide association studies (GWASs) have identified several genetic loci for M-AGA and have provided better insight into the underlying biology. However, the role of heritable factors in female pattern hair loss (FPHL) is largely unknown. Recently published studies have been restricted to candidate gene approaches and could not clearly identify any susceptibility locus/gene for FPHL but suggest the aetiology differs substantially from that of M-AGA. Hypotheses about possible pathomechanisms of FPHL as well as the results of the genetic studies performed to date are summarized. This article is protected by copyright. All rights reserved
Ich kann nicht schweigen! : Tatsachenbericht eines im Jahre 1938 aus seiner Heimatstadt Wien vertriebenen Juden 1938-1945
The main part (48 pages) seems to be the memoir of Tova Tokayer’s father, Henry (Chaskel) Futterweit (writing under a pseudonym), recollecting his flight from Vienna via Switzerland to the United States. In addition, Chas Kelfeit wrote down the dictations of other Jews from Vienna with similar experiences.Contributions by: David Andacht; Sacher Bardach, Matio Lauer, Izak Leizer Lindenbaum, Richard Metzger, Oskar Sonnenschein, Heinrich TrawniczekdigitizedThe typescript was donated by Tova Tokayer, with the understanding that her father Chaskel (Henry) Futterweit had written down the dictations of others.Donated by Tova Tokayer via AHCAustrian Heritage Collectio
Pulmonary Embolism Complicating Human Chorionic Gonadotropin Treatment in a Patient with Type IV Hyperlipoproteinemia
- …